CFC Big Ideas served as a Ukrainian communications advisor to STADA Group, a global manufacturer of high-quality generic and consumer healthcare products. CFC offered this service in connection with the acquisition of the pharmaceutical business of Biopharma, one of the key pharmaceutical producers in Ukraine.
With this step, STADA has made one of the largest financial investments in the Ukrainian pharmaceutical sector so far and one of the biggest foreign investments in the country in recent history.
“We see great potential in the Ukrainian market. With this acquisition, we will become an important player in the Ukrainian pharma market with a strong local production footprint,” emphasizes STADA CEO Peter Goldschmidt.
For CFC Big Ideas, the support of this acquisition reaffirmed the agency’s public affairs expertise in the pharmaceutical and healthcare industries. In 2015, CFC Big Ideas served as an advisor to Biopharma during the launch of a new biotechnology plant in Bila Tserkva, and since 2018 the agency has been a communications consultant to the World Bank’s “Serving People, Improving Health” Project” in Poltava and Dnipro.